Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV Clinic

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages 1315-1318

  Willig, James H ^a,d   Jackson, David A ^a   Westfall, Andrew O ^c   Allison, Jeroan ^b   Chang, Pei Wen ^a   Raper, James ^a   Saag, Michael S ^a   Mugavero, Michael J ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ALABAMA; COHORT STUDIES; FATIGUE; FEMALE; HIV INFECTIONS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 42549164770     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/533466     Document Type: Article

References (13)

1. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy: results from the DAD study. AIDS 2003; 17:1179-93.
2. Glass TR, Ungsedhapand C, Wolbers M, et al. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med 2006; 7:404-10.
3. DAD Study Group, Friis-Møller N, Reiss P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-35.
4. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352:48-62.
5. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135:825-34.
6. O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in patient safety: from research to implementation. Vol 2. Concepts and methodology. Rockville, MD: Agency for Healthcare Research and Quality, 2005:293-308.
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
8. Goldberg KC, Melnyk SD, Simel DL. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol. Am J Manag Care 2007; 13:530-4.
9. Rodondi N, Peng T, Karter AJ, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia and diabetes mellitus. Ann Intern Med 2006; 144:475-84.
10. Kim C, Hofer TP, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women: a conceptual model. J Gen Intern Med 2003; 18:854-63.
11. Abuful A, Gidron Y, Henkin Y. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol 2005; 28:389-93.
12. Hirschhorn LR, McInnes K, Landon BE, et al. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues 2006; 16:104-12.
13. Fultz SL, Goulet JL, Weissman S, et al. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis 2005; 41:738-43.